Michele Magni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade.
Journal: Scientific reports
Published: November 06, 2023
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells.
Journal: Journal for immunotherapy of cancer
Published: May 08, 2021
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term.
Journal: Bone marrow transplantation
Published: February 07, 2021
Reproductive parameters in some captive-bred cockatoo species (genus Cacatua and Eolophus).
Journal: Veterinary record open
Published: March 24, 2020
Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Journal: International journal of radiation oncology, biology, physics
Published: July 21, 2015
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation.
Journal: Urologic oncology
Published: January 20, 2015
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy.
Journal: Future oncology (London, England)
Published: June 21, 2014
Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.
Journal: International journal of cancer
Published: September 19, 2013
Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.
Journal: Clinical genitourinary cancer
Published: September 12, 2013
Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2013
Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma.
Journal: American journal of blood research
Published: February 20, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026